-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2024-511054-50-00
10
HIV-1 Infection
-
2024-513740-28-00
5
Respiratory Syncytial Virus and Human Metapneumovirus
-
2024-513778-23-00
5
Colon and rectal cancer tumor stage II-III, tumor with somatic alterat
-
2024-513894-35-00
4
Depression
-
2024-516115-24-00
9
High risk relapsed neuroblastoma (relapsed or progressed after being d
-
2024-516228-33-00
6
Type 2 Diabetes
-
2024-516723-14-00
6
Rheumatoid Arthritis
-
2024-517082-16-01
5
Post medical abortion contraception
-
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
-
2024-518120-68-01
4
Paraphilic disorder, Compulsive sexual behavior disorder
-
2024-518977-32-00
5
Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and non-Hodgkin) ans
-
2024-519407-99-00
6
Major depressive disorder
-
2024-520141-23-01
5
RSV infection
-
2025-521045-24-00
5
Stage III colorectal cancer
-
2025-521590-13-00
5
Moderately to Severely Active Crohn’s Disease
-
2025-521795-58-00
11
Abdominal aortic aneurysm
-
2025-522399-10-00
5
Vestibular neuritis
-
2025-522580-15-00
4
Amyotrophic Lateral Sclerosis (ALS)
-
2025-522633-57-00
1
Prevention of Cholera disease
-
2025-522698-13-00
6
Influenza, Obesity, Type 2 diabetes
-
2025-522955-25-00
6
Rectal cancer
-
2025-522983-33-00
5
Chronic rhinosinusitis with nasal polyps
-
2025-523465-21-00
5
Fibromyalgia